WADA releases list of prohibited substances in 2020

Image
ANI Others
Last Updated : Jan 01 2020 | 11:55 AM IST

World Anti Doping Agency (WADA) on Monday released a list of substances and methods that are prohibited in 2020.

The list constitutes Anabolic agents like androgenic steroids, peptide hormones, growth factors, and mimetics like Erythropoietin (EPO), beta-2 agonists including all optical isomers like Fenoterol and Formoterol.

The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 40 ng/mL is not consistent with therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of a therapeutic dose (by inhalation) up to the maximum dose indicated above.

The list also barred hormone and metabolic modulators, diuretics and masking agents, as well as other substances with a similar chemical structure or similar biological effects.

All-natural and synthetic cannabinoids are prohibited, glucocorticoids are prohibited when administered by oral, intravenous, intramuscular or rectal routes.

WADA's compliance review committee (CRC) had suggested several sanctions because of the Russian Anti-Doping Agency's (RUSADA) failure to cooperate fully during probes into Russian sport, CNN had reported.

WADA's executive committee decided to uphold the recommendations at a meeting in Lausanne, Switzerland.

It is being alleged that Russia manipulated a database to delete some test results and fabricate other data.

Three years ago, Russia was caught in one of the most controversial doping programs in sports history.

In the program, Russian anti-doping experts and members of the country's intelligence service replaced urine samples tainted by performance-enhancing drugs with clean urine at the 2014 Winter Olympics in Sochi, Russia.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 01 2020 | 11:42 AM IST

Next Story